SHANGHAI (Reuters) - China's top economic planning agency has opened an investigation into pharmaceutical giant GlaxoSmithKline Plc's operations in China, an official newspaper reported on Thursday, as foreign firms come under pressure from Beijing for possible price-fixing. The National Development and Reform Commission (NDRC) has begun a survey on production costs at 60 firms, including Britain's GlaxoSmithKline and 10 China-listed firms, the official Securities Daily said. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment